{
    "clinical_study": {
        "@rank": "85857", 
        "acronym": "RENASICA_III", 
        "brief_summary": {
            "textblock": "The Registry pretends to identify stratification, diagnosis and treatment approaches in\n      patients with Acute Coronary Syndrome (ACS) in community hospitals with tertiary hospitals\n      to optimize resources and identify strategies to improve health care quality through the\n      creation of clinical guidelines that serve for unify management and treatment  methods with\n      adherence to international guidelines which include suggestions for treatment and\n      medication."
        }, 
        "brief_title": "THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Coronary Syndromes", 
        "condition_browse": {
            "mesh_term": "Acute Coronary Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        all patients with suspected ACS and will analyze risk factors, chest pain and\n        electrocardiographic characteristics.\n\n        Exclusion Criteria:\n\n        Patients with secondary ischemia (anaemia, pulmonary thromboembolism, myocarditis) and\n        type II infarction."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "It will include patients older than 18 years with ACS final diagnosis and objective\n        evidence of atherosclerotic coronary disease. Patients will be identified in the emergency\n        department, coronary care units, intensive care units, hospital and hemodynamic\n        laboratories"
            }
        }, 
        "enrollment": {
            "#text": "8296", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02141750", 
            "org_study_id": "RENASICA III"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2014", 
        "number_of_groups": "1", 
        "official_title": "THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Mexico: Mexican Society of Cardiology", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The main objective will be to know the evolution of ACS in third and second level hospitals with a monitoring at a minimum of one year for each patient.", 
            "measure": "Number of patients with complications after presenting  ACS", 
            "safety_issue": "No", 
            "time_frame": "up to one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02141750"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Third National Registry of Acute Coronary Syndromes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Third National Registry of Acute Coronary Syndromes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}